Webinar 1 month ago. 21 mins in there are non dilutive funding opportunities available on successful phase 1 and Walter reed without the need to dilute share holders.
Upto 20 million dollars worth of non dilutive funding to be exact
ok let’s wait and see on Tuesday this week coming they will trade halt and announce a “cap raise 2 million at 9 cents on a 5 day VWAP.” I’m waiting on Tuesday after the public holiday. Company is fully funded through to phase 2 and has significant number of catalysts this quarter derisking safety and taking advantage of a drug that is more superior than first line treatment of FDA drug that has a 4 billion dollar market. Still going to go a lot higher in the period ahead
NYR Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)